Download Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Viscosupplementation Market: By Product, By End User, Others) and Region Forecast 2020-2031
Viscosupplementation Market: By Product, By End User, Others) and Region Forecast 2020-2031
Report ID:53474
Published Date:Apr 2023
No of Pages:
Format:
Viscosupplementation Market size was valued at US$ 2.35 billion in 2024 and is expected to reach US$ 3.67 billion by 2031, growing at a significant CAGR of 6.6% from 2025-2031. The global market provides a detailed overview of the market, which has been segmented by product and end-user. By product, the market has been segmented into Single Injections, Three Injections, and Five injections. The Single Injection segment is likely to be the largest and fastest-growing segment in terms of product type. Based on the end-user, the market is segmented into Hospitals, Orthopedic Clinics/Ambulatory Surgical Centers (ASCs), and Others. According to precision business insights, the Orthopedic Clinics/Ambulatory Surgical Centers (ASCs) segment is predicted to register the fastest growth rate during the forecast period.
Study Period
2025-2031Base Year
2024CAGR
6.6%Largest Market
Asia-PacificFastest Growing Market
Asia-Pacific
The market is likely to be driven by increasing demand for non-surgical treatments for osteoarthritis, the prevalence of lifestyle-induced problems, and developments in creating hyaluronic acid-based therapies.
Asia Pacific is the fastest growing region in the market compared to other regions
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2025-2031 |
|
Market Size in 2024 |
US$ 2.35 billion |
|
Market Size in 2031 |
US$ 3.67 billion |
|
Market CAGR |
6.6% |
|
By Product |
|
|
By End User |
|
|
By Region |
|
Download Free Sample Report
The viscosupplementation market size was valued at US$ 2.35 billion in 2024 and is projected to grow at a significant CAGR of 6.6% from 2025-2031.
The key players in the market are Sanofi, Anika Therapeutics, Inc., Seikagaku Corp., Zimmer Biomet, Smith & Nephew PLC, Ferring Pharmaceuticals B.V., Lifecore Biomedical, LG Life Sciences Ltd., Fidia Farmaceutici S.p.A, F.Hoffmann-La Roche Ltd.
Asia-Pacific is the fastest-growing region for market.
Content Updated Date: Sep 2025
| 1. Executive Summary |
| 2. Global Viscosupplementation Market Introduction |
| 2.1. Global Viscosupplementation Market Taxonomy |
| 2.2. Global Viscosupplementation Market Definitions |
| 2.2.1. By Product |
| 2.2.2. By End User |
| 3. Global Viscosupplementation Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Global Viscosupplementation Market Dynamic Factors - Impact Analysis |
| 3.6. Global Viscosupplementation Market Competition Landscape |
| 4. Global Viscosupplementation Market Analysis,2020 - 2024 and Forecast, 2025 - 2031 |
| 4.1. Market Analysis,2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) (Volume, Tons) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Viscosupplementation Market, By Product, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) (Volume, Tons) |
| 5.1. Single Injection |
| 5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) (Volume, Tons) |
| 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Three Injection |
| 5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) (Volume, Tons) |
| 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Five Injection |
| 5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) (Volume, Tons) |
| 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6. Global Viscosupplementation Market Forecast, By End User, 2019 - 2023 and Forecast, 2020 2026 (Revenue, USD Mn) (Volume, Tons) |
| 6.1. Hospitals |
| 6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) (Volume, Tons) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Orthopedic Clinics/Ambulatory Surgical Centers (ASCs) |
| 6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) (Volume, Tons) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Others |
| 6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) (Volume, Tons) |
| 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7. Global Viscosupplementation Market Forecast, By Region, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) (Volume, Tons) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) (Volume, Tons) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) (Volume, Tons) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia-Pacific |
| 7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) (Volume, Tons) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Latin America |
| 7.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) (Volume, Tons) |
| 7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Middle East and Africa |
| 7.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) (Volume, Tons) |
| 7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 7.6. Global Viscosupplementation Market - Opportunity Analysis Index, By Product, By End User, and Region, 2024 - 2030 |
| 8. North America ViscosupplementationMarketAnalysis,2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) (Volume, Tons) |
| 8.1. Product Analysis 2020 - 2024 and Forecast 2025 - 2031by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1. Single Injection |
| 8.1.2. Three Injection |
| 8.1.3. Five Injection |
| 8.2. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 8.2.1. Hospitals |
| 8.2.2. Orthopedic Clinics/Ambulatory Surgical Centers (ASCs) |
| 8.2.3. Others |
| 8.3. Country Analysis 2020 - 2024 and Forecast 2025 - 2031by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 8.3.1. USA |
| 8.3.2. Canada |
| 8.4. North America Viscosupplementation Market - Opportunity Analysis Index, By Product, By End User, and Country, 2024 - 2030 |
| 8.5. North America Viscosupplementation Market Dynamics Trends |
| 9. Europe Viscosupplementation Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) (Volume, Tons) |
| 9.1. Product Analysis 2020 - 2024 and Forecast 2025 - 2031by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1. Single Injection |
| 9.1.2. Three Injection |
| 9.1.3. Five Injection |
| 9.2. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 9.2.1. Hospitals |
| 9.2.2. Orthopedic Clinics/Ambulatory Surgical Centers (ASCs) |
| 9.2.3. Others |
| 9.3. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 9.3.1. Germany |
| 9.3.2. UK |
| 9.3.3. France |
| 9.3.4. Spain |
| 9.3.5. Italy |
| 9.3.6. Russia |
| 9.3.7. Poland |
| 9.3.8. Rest of Europe |
| 9.4. Europe Viscosupplementation Market - Opportunity Analysis Index, By Product, By End User, and Country,2024 - 2030 |
| 9.5. Europe Viscosupplementation Market Dynamics Trends |
| 10. Asia-Pacific Viscosupplementation Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) (Volume, Tons) |
| 10.1. Product Analysis 2020 - 2024 and Forecast 2025 - 2031by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Single Injection |
| 10.1.2. Three Injection |
| 10.1.3. Five Injection |
| 10.2. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.2.1. Hospitals |
| 10.2.2. Orthopedic Clinics/Ambulatory Surgical Centers (ASCs) |
| 10.2.3. Others |
| 10.3. Country Analysis2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 10.3.1. Japan |
| 10.3.2. China |
| 10.3.3. India |
| 10.3.4. ASEAN |
| 10.3.5. Australia & New Zealand |
| 10.3.6. Rest of Asia-Pacific |
| 10.4. Asia-Pacific Viscosupplementation Market - Opportunity Analysis Index, By Product, By End User, and Country,2024 - 2030 |
| 10.5. Asia-Pacific Viscosupplementation Market Dynamics Trends |
| 11. Latin America Viscosupplementation Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) (Volume, Tons) |
| 11.1. Product Analysis 2020 - 2024 and Forecast 2025 - 2031by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Single Injection |
| 11.1.2. Three Injection |
| 11.1.3. Five Injection |
| 11.2. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.2.1. Hospitals |
| 11.2.2. Orthopedic Clinics/Ambulatory Surgical Centers (ASCs) |
| 11.2.3. Others |
| 11.3. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 11.3.1. Brazil |
| 11.3.2. Mexico |
| 11.3.3. Argentina |
| 11.3.4. Rest of Latin America |
| 11.4. Latin America Viscosupplementation Market - Opportunity Analysis Index, By Product, By End User, and Country,2024 - 2030 |
| 11.5. Latin America Viscosupplementation Market Dynamics Trends |
| 12. Middle East and Africa Viscosupplementation Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) (Volume, Tons) |
| 12.1. Product Analysis 2020 - 2024 and Forecast 2025 - 2031by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Single Injection |
| 12.1.2. Three Injection |
| 12.1.3. Five Injection |
| 12.2. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.2.1. Hospitals |
| 12.2.2. Orthopedic Clinics/Ambulatory Surgical Centers (ASCs) |
| 12.2.3. Others |
| 12.3. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 12.3.1. Gulf Cooperation Council (GCC) Countries |
| 12.3.2. Israel |
| 12.3.3. South Africa |
| 12.3.4. Rest of MEA |
| 12.4. MEA Viscosupplementation Market - Opportunity Analysis Index, By Product, By End User, and Country,2024 - 2030 |
| 12.5. MEA Viscosupplementation Market Dynamics Trends |
| 13. Competition Landscape |
| 13.1. Strategic Dashboard of Top Market Players |
| 13.2. Company Profiles (Introduction, Financial Analysis, End User& Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
| 13.2.1. Allergan |
| 13.2.2. Sanofi |
| 13.2.3. Hoffmann-La Roche |
| 13.2.4. Smith & Nephew Plc |
| 13.2.5. Zimmer Biomet |
| 13.2.6. Anika Therapeutics Inc. |
| 13.2.7. Ferring B.V. |
| 13.2.8. Bioventus |
| 13.2.9. Fidia Farmaceutici S.P.A. |
| 13.2.10. Regen Lab SA |
| 14. Research Methodology |
| 15. Key Assumptions and Acronyms |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.